Health Net
Adakveo (crizanlizumab-tmca)
Drugs for the Blood : Drugs for the Blood
  • Step Therapy Applies
  • Prior Authorization: Sickle Cell Disease:
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Age Requirement: >= 16
    Duration: 6 Month(s)
    Reauthorization Required: Yes

  • Sickle Cell Disease:
    Age Requirement: >= 16
    Duration: 6 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Specialist Type(s): Hematologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)